Country for PR: China
Contributor: Xinhua News Agency
Wednesday, September 30 2020 - 22:32
The 11th China (Taizhou) International Medical Expo ended successfully
NANJING, China, Sept. 30, 2020 /Xinhua-AsiaNet/--

From September 19 to 21, the 11th China (Taizhou) International Medical Expo 
was held at the China Medical City Exhibition Center. With the theme of 
"Development Trends in the Medical and Health Industry under the Epidemic", the 
current medical expo held 23 special events and attracted participants from 21 
countries and regions. Nearly 800 pharmaceutical companies participated in the 
exhibition. After 11 years of professional accumulation, this year's expo 
presents three "higher" characteristics: a higher degree of 
internationalization, a higher degree of specialization, and a higher degree of 
professionalization. This time, the expo also innovatively set up an online 
cloud exhibition, providing services such as online conferences, VR 
exhibitions, and enterprise docking, and building an integrated online and 
offline communication platform.

During the expo, China Medical City released the latest preferential policies 
for investment promotion, involving a total of 25 preferential policies in 7 
major sectors, covering the R&D, production, sales and application of the 
pharmaceutical health industry. Relying on the advantages of abundant financial 
support, complete talent support policies, professional full-process services, 
and complete supporting facilities, China Medical City has built a first-class 
industrial ecosystem, and initially formed antibodies, vaccines, diagnostic 
reagents, high-performance medical equipment and a batch of characteristic 
industrial clusters such as new pharmaceutical preparations and special medical 
formula foods. More than 1,200 pharmaceutical companies, including 13 
world-renowned multinational pharmaceutical companies such as Nestle and 
AstraZeneca, have taken root for development. The expo attracted 24 major 
projects from home and abroad to sign and settle down, with a total investment 
of 19.755 billion yuan, covering many fields such as antibodies, vaccines, and 
high-end medical devices.

The Taizhou Pharmaceutical High-tech Zone continues to promote the provincial 
and ministerial joint construction system to provide support for the 
development of China Medical City. Pharmaceutical companies have successively 
won the "National" brand such as the National Innovative Park, the New Vaccine 
and Specific Diagnostic Reagent Industry Cluster, and the National New Drug and 
Special Industrialization Demonstration Base. Currently in the critical period 
of "second entrepreneurship", Taizhou Pharmaceutical High-tech Zone will follow 
the path of industrialization, specialization, capitalization and 
internationalization, to speed up the construction to become "China's No. 1 and 
World Famous" Medical City.

Source: Taizhou China Medical City

Image Attachments Links:


   Caption: The scene of China (Taizhou) International Medical Expo